Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis

Cameron, Alexandra; Ewen, Margaret; Ross‐Degnan, Dennis; Ball, Douglas J.; Laing, Richard

doi:10.1016/s0140-6736(08)61762-6

Cited by 714 publications

(728 citation statements)

References 6 publications

Supporting

Mentioning

681

Contrasting

Unclassified

Order By: Relevance

“…Estima-se que, no início do século XXI, uma em cada três pessoas no mundo não dispõe de acesso a esses insumos, sendo a pior situação verificada nos países de baixa e média renda, onde essa proporção pode chegar a 50% 2 . Nesses países, em apenas um terço das vezes, as instituições públicas têm os medicamentos essenciais disponíveis quando são procuradas pela população 3 . O acesso aos medicamentos se dá mediante a disponibilidade destes, a capacidade aquisitiva das pessoas, sua acessibilidade geográfica e aceitabilidade, levando ao uso racional do produto 4 .…”

Section: Objetivou-se Descrever a Prevalência E Os Fatores Associadosunclassified

Acesso a medicamentos no setor público: análise de usuários do Sistema Único de Saúde no Brasil

et al. 2013

View full text Add to dashboard Cite

Section: Objetivou-se Descrever a Prevalência E Os Fatores Associadosunclassified

Acesso a medicamentos no setor público: análise de usuários do Sistema Único de Saúde no Brasil

et al. 2013

View full text Add to dashboard Cite

“…Cameron also contends that over time medicines have become unaffordable for a large section of the population and can be a major burden on patients and a barrier towards access to health care [11]. South Africa shares the context as outlined above.…”

Section: Medicine Expenditurementioning

confidence: 99%

What are key determinants of hospital admissions, readmission rate and day case rate within the South African medical schemes population?

Khumalo¹,

Willie²,

Thsehla³

2012

View full text Add to dashboard Cite

BACKGROUND: In South Africa, private hospitals absorb a high proportion of the total health expenditure on private health care. Between 2008-2010 private hospital expenditure which includes ward fees, theatre fees, consumables, medicines and per diem arrangements consumed between 40.5% and 40.9% of the total benefits paid by medical schemes from the risk pool, whilst in-hospital managed care fees ranged between 1.8% and 2.8% for the equivalent years. OBJECTIVE: The aim of this paper is to highlight key factors contributing to utilisation of hospital services within the medical schemes population and to recommend "appropriate" and cost effective strategies on hospital utilisation management. METHODS: A cross sectional survey informed by retrospective analysis of quantitative data was used. Researchers also triangulated quantitative data with systematic review of literature. RESULTS: The results show that demographic indicators such as age profile, dependency ratio, pensioner ratio and prevalence of chronic conditions are not the only key factors influencing hospital admissions, but rather the effectiveness of each medical scheme in containing hospital admissions is also influenced by available technical capacity on utilisation review and audit as well as the managed care methodology including the philosophy underpinning benefit option design. CONCLUSION: This study highlights the importance of "value based" managed care programs linked to benefit option design in health care utilisation management. The choice of one managed care program over the other often leads to tradeoffs whereby unintended consequences emanate. Medical schemes are therefore encouraged to continuously review their managed care programs to ensure value for money as well as better access and health outcomes. Keywords ORIGINAL RESEARCHFarmeconomia. Health economics and therapeutic pathways 2012; 13(2): 83-96

show abstract

“…The country's residents are faced with a high disease burden, due largely to the HIV/AIDS pandemic, as well as to lack of essential healthcare resources and high medicine costs, which affect the availability, accessibility and affordability of essential medicines for a large percentage of the population (Cameron, Ewen, Ross-Degnan, Ball, & Laing, 2009;Gray & Matsebula, 2000).…”

Section: Introductionmentioning

confidence: 99%

“…This is due to the fact that current VAT policies contribute to the decreased accessibility of essential medicines to the poorest of the poor (Cameron et al, 2009), which is counter-active to the objectives of the NDP (Department of Health, 1996). Notably, any savings in the private sector, will contribute to reducing the burden of patients accessing the public sector, hence improving delivery of care.…”

Section: Introductionmentioning

confidence: 99%

Cost-savings accruable to removing value added tax from antiretrovirals in the South African private health sector

Bangalee

Suleman

2017

Health SA Gesondheid

View full text Add to dashboard Cite

a b s t r a c tBackground: Despite the important and essential role that medicines play in any society, all medicines, including those identified as essential, are uniformly subjected to 14% value added tax (VAT), regardless of their therapeutic value in the private healthcare sector of South Africa. The aim of this article is to demonstrate the potential cost-saving attained from the removal of VAT from the private sector pricing of essential medicines, using antiretroviral treatment as an example. h e a l t h s a g e s o n d h e i d 2 2 ( 2 0 1 7 ) 1 5 0 e1 5 6http://dx

show abstract

Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis

Cited by 714 publications

References 6 publications

Acesso a medicamentos no setor público: análise de usuários do Sistema Único de Saúde no Brasil

Acesso a medicamentos no setor público: análise de usuários do Sistema Único de Saúde no Brasil

What are key determinants of hospital admissions, readmission rate and day case rate within the South African medical schemes population?

Cost-savings accruable to removing value added tax from antiretrovirals in the South African private health sector

Contact Info

Product

Resources

About